Intragastric floating drug delivery system of cefuroxime axetil: In vitro evaluation

AAPS PharmSciTech

Volumn 7, Issue 1, 2006, Pages

  Patel, Viral F ^a   Patel, Natavarlal M ^a  

^a Shri B M Shah College of Pharmacy Modasa   (India)

Author keywords

Factorial design; Floating tablets; Hydroxypropyl methylcellulose (HPMC); Sodium lauryl sulfate (SLS)

Indexed keywords

CEFUROXIME AXETIL; DODECYL SULFATE SODIUM; HYDROCHLORIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; FACTORIAL DESIGN; IN VITRO STUDY; MULTIPLE REGRESSION; TABLET COMPRESSION; TABLET FORMULATION; UNITED STATES;

EID: 33644837054     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McEvoy GK, ed. Cephalosporins: cefuroxime sodium and cefuroxime axetil. AHFS Drug Information. Bethesda, MD: American Society of Hospital Pharmacists Inc; 2003:223-231.
2. Wozniak T, Hicks J. Cefuroxime sodium. In: Florey K, ed. Analytical Profiles of Drug Substances. San Diego, CA: Academic Press; 1991:209-237.
3. Ridgway E, Stewart K, Rai G, Kelsey MC, Bielawska C. The pharmacokinetics of cefuroxime axetil in the sick elderly patient. J Antimicrob Chemother. 1991;27:663-668.
4. Sommers D, Van Wyk K, Schoeman H, Moncrieff J. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil. Br J Clin Pharmacol. 1984;18:535-539.
5. Finn A, Straugun A, Meyer M, Chubb J. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos. 1987;8:519-526.
6. McEvoy GK, ed. Cephalosporins: cefuroxime sodium and cefuroxime axetil. AHFS Drug Information. Bethesda, MD: American Society of Hospital Pharmacists Inc; 1994:152-159.
7. Williams P, Harding SM. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food. J Antimicrob Chemother. 1984;13:191-196.
8. Harding SM. Comparative pharmacokinetics of tablets and suspension. Res Clin Forums. 1990;12:23-29.
9. Mosher G, Mc-Bee LJ, Shaw David B. Esterase activity toward the diastereomers of cefuroxime axetil in the rat and the dog. Pharm Res. 1992;9:687-689.
10. Kees F, Lukassek U, Naber KG, Grobecker H. Comparative investigations on the bioavailability of cefuroxime axetil. Arzneimittelforschung, 1991;41:843-846.
11. Glaxo Inc. Profilaxis Antibiotica: Cefuroxima IV Versus Oral. Madrid, Spain: Glaxo Inc; 1994.
12. Ruiz-Balaguer N, Nacher A, Casabo VG, Merino M. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats. Antimicrob Agents Chemother. 1997;41:445-448.
13. Adams DH, Wood MJ, Farrell ID, Fox C, Ball AP. Oral cefuroxime axetil: clinical pharmacological and comparative dose studies in urinary tract infection. J Antimicrob Chemother. 1985; 16:359-366.
14. Sood A, Panchagnula R. Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index. Int J Pharm. 2003;261:27-41.
15. Hoffman A, Dananberg HD, Katzhendler I, Shuval R, Gilhar D, Friedman M. Pharmacodynamic and pharmacokinetic rational for the development of an oral controlled release amoxicillin dosage form. J Control Release. 1998;54:29-37.
16. Yeole PG, Khan S, Patel VF. Floating drug delivery systems: need and development. Indian J Pharm Sci. 2005;67:265-272.
17. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005; 6:E372-E390.
18. Colombo P, Bettini R, Peppas NA. Observation of swelling process and diffusion front position during swelling in HPMC matrices containing soluble drug. J Control Release. 1999; 61:83-91.
19. Dow Chemical Co. Methocel: Cellulose Ethers Technical Handbook. San Diego, CA, USA: Dow Chemical Co; 1996:18-20.
20. Dortunc B, Gunal N. Release of acetazolamide from swellable HPMC matrix tablets. Drug Dev Ind Pharm. 1997; 23:1245-1249.